Nucleolin acts as a co-receptor for several growth factors and participates in different signaling pathways sustaining tumor cell growth, prompting several laboratories, including ours, to design synthetic nucleolin antagonists [4]. The gene discussed is NUCLEOLIN; the disease is neoplasm.